<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Prevalence and genetic variants of hepatitis GB-C/HG and TT viruses in Gabon, Equatorial Africa</dc:title>
  <dc:creator>Tuveri, R.</dc:creator>
  <dc:creator>Perret, J.L.</dc:creator>
  <dc:creator>/Delaporte, Eric</dc:creator>
  <dc:creator>Nguemby-Mbina, C.</dc:creator>
  <dc:creator>Revault d'Allones, L.</dc:creator>
  <dc:creator>Henzel, D.</dc:creator>
  <dc:creator>Faivre, D.</dc:creator>
  <dc:creator>Scarpa, B.</dc:creator>
  <dc:creator>Contu, P.</dc:creator>
  <dc:creator>Colombo, M.</dc:creator>
  <dc:creator>Thiers, V.</dc:creator>
  <dc:creator>Br&#xE9;chot, C.</dc:creator>
  <dc:creator>Larouze, B.</dc:creator>
  <dc:subject>MALADIE</dc:subject>
  <dc:subject>EPIDEMIE</dc:subject>
  <dc:subject>VIRUS</dc:subject>
  <dc:subject>INFECTION</dc:subject>
  <dc:subject>PREVALENCE</dc:subject>
  <dc:subject>DISTRIBUTION</dc:subject>
  <dc:subject>ANALYSE GENETIQUE</dc:subject>
  <dc:subject>METHODE D'ANALYSE</dc:subject>
  <dc:subject>TECHNIQUE PCR</dc:subject>
  <dc:subject>TEST ELISA</dc:subject>
  <dc:subject>PHYLOGENIE</dc:subject>
  <dc:subject>ETUDE EXPERIMENTALE</dc:subject>
  <dc:subject>ETUDE COMPARATIVE</dc:subject>
  <dc:subject>HEPATITE</dc:subject>
  <dc:subject>TUBERCULOSE</dc:subject>
  <dc:description>The distribution of Hepatitis GB-C/HG (GB-C/HG) and TT viruses (TTV) infections was investigated in selected populations from Gabon using Polymerase Chain Reaction (PCR) and Enzyme Linked Immunosorbent Assay (ELISA) for anti-Envelop 2 (anti-E2) GBV-C/HGV RNA positive (+) and 32 of 81 (39.5%) anti-E2 + versus 8 of 39 (20.5%) TTV DNA +. For tuberculosis patients, the figures were 11.5% (4/35) and 0%. A study of hepatocellular carcinoma cases (n = 27) versus controls (n = 66) did not show significant differences for GBV-C/HGV RNA (10.7% versus 12.1%) and TTV DNA (44.4% versus 30.3%). According to phylogenetic analysis, the 15 GBV-C/HGV strains investigated clustered in group 1, the most common in sub-Saharan Africa whereas TTV sequences (n = 4) mostly clustered in genotypes G1 and one close to genotype G3. In the Gabonese populations investigated, GBV-C/HGV and TTV infections were highly endemic. These data are consistent with the low pathogenicity of these agents. (R&#xE9;sum&#xE9; d'auteur)</dc:description>
  <dc:date>2000</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010025991</dc:identifier>
  <dc:identifier>fdi:010025991</dc:identifier>
  <dc:identifier>Tuveri R., Perret J.L., Delaporte Eric, Nguemby-Mbina C., Revault d'Allones L., Henzel D., Faivre D., Scarpa B., Contu P., Colombo M., Thiers V., Br&#xE9;chot C., Larouze B.. Prevalence and genetic variants of hepatitis GB-C/HG and TT viruses in Gabon, Equatorial Africa. 2000, 63 (3,4),  192-198</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>GABON</dc:coverage>
  <dc:coverage>LIBREVILLE</dc:coverage>
</oai_dc:dc>
